Q4 2017 Holdings
Filed 2018-03-02 | 65 holdings | $43.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $8.5K | 51,496 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $8.7K | 72,441 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $8.8K | 122,784 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $10.7K | 315,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $11.3K | 75,422 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $12.5K | 410,334 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $12.6K | 211,000 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $15.4K | 40,830 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $19.8K | 190,022 | 0.0% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $928.0K | 9,500 | 2.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.1M | 20,000 | 2.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $4.7M | 36,800 | 10.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $6.1M | 68,384 | 13.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $10.0M | 333,773 | 22.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $20.7M | 65,008 | 47.2% |